Home
Scholarly Works
Clinical Pharmacology of CTL019 in Patients with...
Conference

Clinical Pharmacology of CTL019 in Patients with Relapsed/Refractory (r/r) Diffuse Large B-Cell Lymphoma (DLBCL)

Authors

Awasthi R; Tam CS; Jaeger U; Jaglowski S; Foley SR; Van Besien K; Wagner-Johnston ND; Kersten MJ; Schuster SJ; Salles GA

Volume

130

Publisher

AMER SOC HEMATOLOGY

Publication Date

December 7, 2017

Name of conference

59th Annual Meeting of the American-Society-of-Hematology (ASH)

Conference place

GA, Atlanta

Conference start date

December 9, 2017

Conference end date

December 12, 2017

Conference proceedings

BLOOD

ISSN

0006-4971

Contact the Experts team